<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04867629</url>
  </required_header>
  <id_info>
    <org_study_id>DOC</org_study_id>
    <nct_id>NCT04867629</nct_id>
  </id_info>
  <brief_title>Impact of Rapeseed and Sunflower Oils on Proteomic Biomarkers of Diseases.</brief_title>
  <acronym>DOC</acronym>
  <official_title>No Evidence of Impact of Seed Oil Intake on Biomarkers of Coronary Artery Disease, Chronic Kidney Disease and Diabetes in Healthy Adults With Overweight and Obesity - Result From a Blinded Randomised Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Glasgow</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Glasgow</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will test the impact of vegetable oils with contrasting fatty acids composition on&#xD;
      biomarkers of health (cardiovascular, kidney diseases and diabetes) after twelve weeks&#xD;
      supplementation. We will use sunflower oil (high in PUFAs), rapeseed oil (high in MUFAs,&#xD;
      locally produced) and a non-intervention control. We have developed a sensitive and selective&#xD;
      urinary proteomic biomarker of cardiovascular disease which we will use in a double-blinded&#xD;
      randomised study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The intervention follows a parallel double-blind randomised control design. The intervention&#xD;
      duration is 12 weeks, with a mid-point assessment at 6 weeks. Randomisation to groups;&#xD;
      rapeseed oil, sunflower oil or habitual diet is performed using a block stratified allocation&#xD;
      based on age (under or over 45) and BMI (under or over 30kg/m2) and is carried out remotely&#xD;
      via phone.&#xD;
&#xD;
      Participants allocated to either oil groups are instructed to consume the oils uncooked, as a&#xD;
      partial replacement to their habitual fat intake. Participants in the control group are asked&#xD;
      to not change any aspect of their diet.&#xD;
&#xD;
      Spot urine samples are collected from all participants at all time points for measurement of&#xD;
      the primary outcome (proteomic biomarker score). Urine is collected in a plastic tube,&#xD;
      mid-flow, as the second urination of the day at baseline, 6 and 12 weeks.&#xD;
&#xD;
      Fasting venous blood is collected for the assessment of secondary outcomes, at baseline, 6&#xD;
      weeks and 12 weeks. Participants are also asked to complete a 2-day food diary at weeks 0, 6&#xD;
      and 12&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2015</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A randomized, double-blind, placebo-controlled trial</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Oils were in identical amber glass bottles labelled A or B. Oils blinded to participants and investigators. However, the control group was unblinded due to them not receiving any intervention</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Proteomic biomarkers</measure>
    <time_frame>0, 6, 12 weeks</time_frame>
    <description>Changes in proteomic biomarker scores of coronary artery disease (CAD238), chronic kidney disease (CKD273)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood lipids</measure>
    <time_frame>0, 6, 12 weeks</time_frame>
    <description>Changes in concentrations of plasma glucose, triglycerides, total cholesterol, high density lipoprotein,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammation markers</measure>
    <time_frame>0, 6, 12 weeks</time_frame>
    <description>Changes in concentrations of plasma interleukin 6, tumor necrosis factor, matrix metallopeptidase 9</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidative stress biomarkers</measure>
    <time_frame>0, 6, 12 weeks</time_frame>
    <description>Changes in concentrations of plasma fructosamine, AGE, RAGE</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">84</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>Rapeseed oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants asked to consume 20mL of rapeseed oil raw every day for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sunflower oil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants asked to consume 20mL of sunflower oil raw every day for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Habitual diet</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants asked to maintain their habitual diet for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Rapeseed oil</intervention_name>
    <description>20mL of rapeseed oil to be consumed daily in replacement to habitual oil</description>
    <arm_group_label>Rapeseed oil</arm_group_label>
    <other_name>RO</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Sunflower oil</intervention_name>
    <description>20mL of sunflower oil to be consumed daily in replacement to habitual oil</description>
    <arm_group_label>Sunflower oil</arm_group_label>
    <other_name>SO</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Overweight adults with a BMI&gt;25 and/or a large waist (Male &gt;102cm and female &gt;88cm),&#xD;
&#xD;
          -  Aged 25-75 years&#xD;
&#xD;
          -  No history of chronic disease of the GI tract&#xD;
&#xD;
          -  Not taking medication (other than the contraceptive pill).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or lactating&#xD;
&#xD;
          -  Allergy to any vegetable oils and vegetable oil-derived products&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Glasgow</name>
      <address>
        <city>Glasgow</city>
        <state>Scotland</state>
        <zip>G12 8QE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 27, 2021</study_first_submitted>
  <study_first_submitted_qc>April 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 30, 2021</study_first_posted>
  <last_update_submitted>April 27, 2021</last_update_submitted>
  <last_update_submitted_qc>April 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Glasgow</investigator_affiliation>
    <investigator_full_name>Emilie Combet</investigator_full_name>
    <investigator_title>Senior lecturer</investigator_title>
  </responsible_party>
  <keyword>rapeseed oil</keyword>
  <keyword>sunflower oil</keyword>
  <keyword>proteomics</keyword>
  <keyword>cardiometabolic</keyword>
  <keyword>cardiovascular</keyword>
  <keyword>fatty acids</keyword>
  <keyword>monounsaturated fatty acids</keyword>
  <keyword>seed oils</keyword>
  <keyword>dietary fat</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

